(HMEF) HSBC MSCI Emerging Markets - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: IE00B5SSQT16 • Global Emerging Markets Equity
HMEF: Stocks, Bonds, Emerging Markets, Investments
HSBC MSCI Emerging Markets UCITS ETF USD (SW:HMEF) is an exchange-traded fund designed to track the performance of the MSCI Emerging Markets Index. This index is a market cap-weighted benchmark that includes large and mid-cap stocks across 24 emerging market countries. The fund is domiciled in Ireland, which provides a stable regulatory environment and potential tax efficiencies for European investors.
With an AUM of $2.16 billion, this ETF offers a diversified exposure to emerging markets, spanning across key regions such as Asia, Latin America, and EMEA. The funds structure allows it to capture the growth potential of emerging economies while maintaining a focus on liquidity and tradability. The expense ratio of 0.68% reflects the cost of managing and replicating the index, which is competitive within its peer group.
Investors should note that this ETF is listed on the Swiss exchange under the ticker HMEF, making it accessible to a broad range of investors, including those in Europe and beyond. The funds underlying index, the MSCI Emerging Markets Index, is widely regarded as a benchmark for emerging market equity performance, providing exposure to companies such as Alibaba, Tencent, and Samsung Electronics.
For portfolio managers and investors, this ETF offers a straightforward way to gain exposure to emerging markets without the need for direct stock selection. However, it’s important to consider the risks associated with emerging markets, including currency fluctuations, political instability, and economic volatility. The fund’s diversification across multiple countries and sectors helps mitigate some of these risks, but investors should still evaluate their risk tolerance and investment horizon before allocating to this asset class.
Additional Sources for HMEF ETF
HMEF ETF Overview
Market Cap in USD | 2,167m |
Category | Global Emerging Markets Equity |
TER | 0.15% |
IPO / Inception | 2011-09-05 |
HMEF ETF Ratings
Growth 5y | 23.2% |
Fundamental | - |
Dividend | 19.3% |
Rel. Strength Industry | 2.61 |
Analysts | - |
Fair Price Momentum | 10.13 USD |
Fair Price DCF | - |
HMEF Dividends
Dividend Yield 12m | 2.38% |
Yield on Cost 5y | 3.23% |
Annual Growth 5y | -66.98% |
Payout Consistency | 100.0% |
HMEF Growth Ratios
Growth Correlation 3m | 64% |
Growth Correlation 12m | 80.6% |
Growth Correlation 5y | -30.2% |
CAGR 5y | 9.63% |
CAGR/Max DD 5y | 0.22 |
Sharpe Ratio 12m | 0.02 |
Alpha | 9.13 |
Beta | 0.80 |
Volatility | 20.85% |
Current Volume | 0.3k |
Average Volume 20d | 1k |
As of March 14, 2025, the stock is trading at USD 11.07 with a total of 300 shares traded.
Over the past week, the price has changed by -1.86%, over one month by -0.36%, over three months by +0.89% and over the past year by +8.37%.
Neither. Based on ValueRay Analyses, HSBC MSCI Emerging Markets is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 23.23 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HMEF as of March 2025 is 10.13. This means that HMEF is currently overvalued and has a potential downside of -8.49%.
HSBC MSCI Emerging Markets has no consensus analysts rating.
According to ValueRays Forecast Model, HMEF HSBC MSCI Emerging Markets will be worth about 11.3 in March 2026. The stock is currently trading at 11.07. This means that the stock has a potential upside of +2.17%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 11.3 | 2.2% |